Oncolytics Biotech® Announces Phase 1b Data Demonstrati

/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced phase 1b data demonstrating clinical proof-of-concept for...

Related Keywords

New Orleans , Louisiana , United States , Canada , New Orleans Convention Center , American , Canadian , Kevin Kelly , Jon Patton , Timothy Mccarthy , Thomas Heineman , Oncolytics Biotech Inc , United States National Cancer Institute , Company Contact , Ernestn Morial Convention Center , Nasdaq , Orleans Convention Center , American Association For Cancer Research , Oncolytics Biotech , Securities Exchange , Bristol Myers Squibb , American Association , Cancer Research , Annual Meeting , Convention Center , Associate Professor , Clinical Medicine , Keck School , Southern California , Principal Investigator , Chief Medical Officer , Tumor Biology , Technical Approaches , Tumor Microenvironment , Wednesday April , Exhibit Hallsd H , Poster Section , Board Number , Securities Exchange Act ,